117 related articles for article (PubMed ID: 22383483)
1. A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research.
Longini IM
Pediatrics; 2012 Mar; 129 Suppl 2():S63-7. PubMed ID: 22383483
[TBL] [Abstract][Full Text] [Related]
2. Expanding the recommendations for annual influenza vaccination to school-age children in the United States.
Fiore AE; Epperson S; Perrotta D; Bernstein H; Neuzil K
Pediatrics; 2012 Mar; 129 Suppl 2():S54-62. PubMed ID: 22383482
[TBL] [Abstract][Full Text] [Related]
3. The Japanese experience with vaccinating schoolchildren against influenza.
Reichert TA; Sugaya N; Fedson DS; Glezen WP; Simonsen L; Tashiro M
N Engl J Med; 2001 Mar; 344(12):889-96. PubMed ID: 11259722
[TBL] [Abstract][Full Text] [Related]
4. Population-wide benefits of routine vaccination of children against influenza.
Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
[TBL] [Abstract][Full Text] [Related]
5. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years.
Prosser LA; Meltzer MI; Fiore A; Epperson S; Bridges CB; Hinrichsen V; Lieu TA
Arch Pediatr Adolesc Med; 2011 Feb; 165(2):112-8. PubMed ID: 20921341
[TBL] [Abstract][Full Text] [Related]
6. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
Schmier J; Li S; King JC; Nichol K; Mahadevia PJ
Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044
[TBL] [Abstract][Full Text] [Related]
7. School-based influenza immunization.
Hull HF; Frauendienst RS; Gundersen ML; Monsen SM; Fishbein DB
Vaccine; 2008 Aug; 26(34):4312-3. PubMed ID: 18577411
[TBL] [Abstract][Full Text] [Related]
8. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
9. Public health. Community studies for vaccinating schoolchildren against influenza.
Halloran ME; Longini IM
Science; 2006 Feb; 311(5761):615-6. PubMed ID: 16456066
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
11. Optimizing influenza vaccine distribution.
Medlock J; Galvani AP
Science; 2009 Sep; 325(5948):1705-8. PubMed ID: 19696313
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
[TBL] [Abstract][Full Text] [Related]
13. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
Hibbert CL; Piedra PA; McLaurin KK; Vesikari T; Mauskopf J; Mahadevia PJ
Vaccine; 2007 Nov; 25(47):8010-20. PubMed ID: 17936446
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
[TBL] [Abstract][Full Text] [Related]
16. Universal influenza vaccination and live attenuated influenza vaccination of children.
Glezen WP
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
Arnoux S; Weinberger C; Gessner BD
Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
[TBL] [Abstract][Full Text] [Related]
18. History of influenza vaccination programs in Japan.
Hirota Y; Kaji M
Vaccine; 2008 Nov; 26(50):6451-4. PubMed ID: 18573292
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of influenza vaccination of healthy children.
Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
[TBL] [Abstract][Full Text] [Related]
20. Vaccinating Japanese schoolchildren against influenza.
Yamazaki T; Suzuki T; Yamamoto K
N Engl J Med; 2001 Jun; 344(25):1947; author reply 1947-8. PubMed ID: 11419437
[No Abstract] [Full Text] [Related]
[Next] [New Search]
